What we do

Emerge Australia is a national organisation providing information, support and advocacy for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Our work gives hope and help to more than 250,000 Australians living with ME/CFS.

The impacts of ME/CFS can be devastating, leaving 25% of patients housebound or bedbound, with many people unable to work or participate in community life. People living with ME/CFS often feel invisible due to the unknown cause of the condition, lack of effective treatment options and limited community awareness, leading many to 'go missing' from their own lives.

In order to continue our essential work, Emerge Australia relies on generous support from the community as we continue to lobby for increased public awareness and funding for biomedical research.

Our mission

To support, provide information and advocacy for people associated with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS).

Our vision

Universal awareness and acknowledgement of ME/CFS as a medical condition.

Our values

To serve the best interests of people affected by ME/CFS with integrity, compassion and empathy.

Our work

We provide expertise on issues to do with ME/CFS at a national level
We host a range of community, national and international events that aim to increase awareness of ME/CFS as a biomedical illness
We provide a variety of resources, as well as news and updates, for people living with ME/CFS
We provide a telehealth nurse service to help meet the needs of people living with ME/CFS
We advocate for systemic reform to improve access to financial and social supports, and to improve access to better healthcare for people living with ME/CFS
We lobby for increases in community support for people with the disease and to drive more biomedical research into ME/CFS

Latest

Research Digest 07/08/20

Welcome to the 53rd edition of the Research Digest. This fortnight's edition features a ME/CFS focused edition of the journal WORK: A Journal of Prevention, Assessment and Rehabilitation.
Research Digest 24/07/20

Welcome to the 52nd edition of the Research Digest. This fortnight's edition features a doppler study of cerebral blood flow when performing a 70-degree head-up tilt test and a perspective paper that discuses ways in which healthcare practitioners can support and provide care to ME/CFS patients.
Research Digest 10/07/20

Welcome to the 51st edition of the Research Digest featuring a study aimed at identifying possible epidemiological and/or clinical factors that could be associated with PEM severity and a UK study into the factors that influence the frequency of GP visits by patients with ME/CFS.
Research Digest 26/06/20

Welcome to the 50th edition of the Research Digest! This edition features a study comparing subjective and objective measures of physical activity in ME/CFS patients and a study that measured and assessed factors that impact on health-related quality-of-life measures in adolescents.

Coronavirus and ME - Simplified facts

Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.
Diagnosis

How a diagnosis of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) is made, the severity scale of ME/CFS, and the importance of early and accurate diagnosis
Accessibility
What is fibromyalgia?

Fibromyalgia is an associated condition of ME/CFS
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
Research Digest 03/04/20

Welcome to the 44th edition of the Research Digest. This edition features a recently published book that highlights the value of biomedical research in ME/CFS and a systematic review into the effect of treatment interventions on pain scores in paediatric ME/CFS patients.
Research Digest 15/05/20

Welcome to the 47th edition of the Research Digest. This fortnight's edition digests a whole brain MRS study looking at metabolite abnormalities in the brains of ME/CFS patients and a French study investigating muscle excitability in exercising and resting muscles of patients diagnosed with ME/CFS.
Treatment and management

The goal of treatment for people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) is to improve a patient's quality of life and to provide relief from symptoms.
Research Digest 10/07/20

Welcome to the 51st edition of the Research Digest featuring a study aimed at identifying possible epidemiological and/or clinical factors that could be associated with PEM severity and a UK study into the factors that influence the frequency of GP visits by patients with ME/CFS.
Coronavirus and ME

We know that many people with ME/CFS (as well as those caring for them) are experiencing concern about the spread of, and possibly contracting, coronavirus. We recognise that people with chronic illness have valid reasons for additional caution at this time.